Locations:
Search IconSearch
January 10, 2017/Opinion

Dr. Brian Bolwell in U.S. News: Addressing the Waiting Game in Cancer Treatment

The average time it takes a newly diagnosed cancer patient to begin treatment is 44 days. The medical system needs to fix that.

Media Contact

Cleveland Clinic News Service | 216.444.0141

We’re available to shoot custom interviews & b-roll for media outlets upon request.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

Cancer Cell

Bolwell, Brian, M.D., chairman, Cleveland Clinic Cancer Center
Bolwell, Brian, M.D., chairman, Cleveland Clinic Cancer Center

The average time it takes a newly diagnosed cancer patient to begin treatment (known as Time to Treat, or TTT) in our most respected academic cancer centers is 44 days. And, unfortunately, TTT is getting worse by the year, Brian Bolwell, M.D., chairman of the Cleveland Clinic Cancer Center, writes in a U.S. News op-ed.

However, the solution is straightforward: Physicians need to commit to multidisciplinary care and form integrated practice units that has the patient at the center of priorities. TTT needs to be measured and emphasized. And we must ask patients what is important to them and not assume that we already know the answer.

Read the entire piece at usnews.com: Addressing the Waiting Game in Cancer Treatment

Latest from the Newsroom

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study